{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T01:08:40Z","timestamp":1794877720284,"version":"4.9.1"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,2]],"date-time":"2023-06-02T00:00:00Z","timestamp":1685664000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,2]],"date-time":"2023-06-02T00:00:00Z","timestamp":1685664000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Nasopharyngeal cancer (NPC) has a unique histopathology compared with other head and neck cancers. Individual NPC patients may attain different outcomes. This study aims to build a prognostic system by combining a highly accurate machine learning model (ML) model with explainable artificial intelligence to stratify NPC patients into low and high chance of survival groups. Explainability is provided using Local Interpretable Model Agnostic Explanations (LIME) and SHapley Additive exPlanations (SHAP) techniques. A total of 1094 NPC patients were retrieved from the Surveillance, Epidemiology, and End Results (SEER) database for model training and internal validation. We combined five different ML algorithms to form a uniquely stacked algorithm. The predictive performance of the stacked algorithm was compared with a state-of-the-art algorithm\u2014extreme gradient boosting (XGBoost) to stratify the NPC patients into chance of survival groups. We validated our model with temporal validation (n\u2009=\u2009547) and geographic external validation (Helsinki University Hospital NPC cohort, n\u2009=\u200960). The developed stacked predictive ML model showed an accuracy of 85.9% while the XGBoost had 84.5% after the training and testing phases. This demonstrated that both XGBoost and the stacked model showed comparable performance. External geographic validation of XGBoost model showed a c-index of 0.74, accuracy of 76.7%, and area under curve of 0.76. The SHAP technique revealed that age of the patient at diagnosis, T-stage, ethnicity, M-stage, marital status, and grade were among the prominent input variables in decreasing order of significance for the overall survival of NPC patients. LIME showed the degree of reliability of the prediction made by the model. In addition, both techniques showed how each feature contributed to the prediction made by the model. LIME and SHAP techniques provided personalized protective and risk factors for each NPC patient and unraveled some novel non-linear relationships between input features and survival chance. The examined ML approach showed the ability to predict the chance of overall survival of NPC patients. This is important for effective treatment planning care and informed clinical decisions. To enhance outcome results, including survival in NPC, ML may aid in planning individualized therapy for this patient population.<\/jats:p>","DOI":"10.1038\/s41598-023-35795-0","type":"journal-article","created":{"date-parts":[[2023,6,2]],"date-time":"2023-06-02T08:08:52Z","timestamp":1685693332000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":169,"title":["Machine learning explainability in nasopharyngeal cancer survival using LIME and SHAP"],"prefix":"10.1038","volume":"13","author":[{"given":"Rasheed Omobolaji","family":"Alabi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Elmusrati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilmo","family":"Leivo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alhadi","family":"Almangush","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antti A.","family":"M\u00e4kitie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,2]]},"reference":[{"key":"35795_CR1","doi-asserted-by":"crossref","unstructured":"Chiang, C. L. et al. Prognostic factors for overall survival in nasopharyngeal cancer and implication for TNM staging by UICC: A systematic review of the literature. Front. Oncol. 11, (2021).","DOI":"10.3389\/fonc.2021.703995"},{"key":"35795_CR2","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3322\/caac.21262","volume":"65","author":"LA Torre","year":"2015","unstructured":"Torre, L. A. et al. Global cancer statistics, 2012: Global Cancer Statistics, 2012. CA Cancer J. Clin. 65, 87\u2013108 (2015).","journal-title":"CA Cancer J. Clin."},{"key":"35795_CR3","first-page":"1141","volume":"12","author":"K Wei","year":"2011","unstructured":"Wei, K., Xu, Y., Liu, J., Zhang, W. & Liang, Z. Histopathological classification of nasopharyngeal carcinoma. Asian Pac. J. Cancer Prev. 12, 1141\u20131147 (2011).","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"35795_CR4","doi-asserted-by":"crossref","unstructured":"El-Naggar, A. K., Chan, J. K. C., Takata, T., Grandis, J. R. & Slootweg, P. J. The fourth edition of the head and neck World Health Organization blue book: Editors\u2019 perspectives. Hum. Pathol. 66, 10\u201312 (2017).","DOI":"10.1016\/j.humpath.2017.05.014"},{"key":"35795_CR5","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1002\/cncr.31031","volume":"124","author":"WB Huang","year":"2018","unstructured":"Huang, W. B., Chan, J. Y. W. & Liu, D. L. Human papillomavirus and World Health Organization type III nasopharyngeal carcinoma: Multicenter study from an endemic area in Southern China: Human Papillomavirus and NPC. Cancer 124, 530\u2013536 (2018).","journal-title":"Cancer"},{"key":"35795_CR6","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.humpath.2018.07.009","volume":"81","author":"A Almangush","year":"2018","unstructured":"Almangush, A. et al. Tumor-infiltrating lymphocytes associate with outcome in nonendemic nasopharyngeal carcinoma: A multicenter study. Hum. Pathol. 81, 211\u2013219 (2018).","journal-title":"Hum. Pathol."},{"key":"35795_CR7","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1080\/0284186X.2017.1346378","volume":"57","author":"M Ruuskanen","year":"2018","unstructured":"Ruuskanen, M. et al. Outcome of nasopharyngeal carcinoma in Finland: A nationwide study. Acta Oncol. 57, 251\u2013256 (2018).","journal-title":"Acta Oncol."},{"key":"35795_CR8","doi-asserted-by":"publisher","first-page":"20190244","DOI":"10.1259\/bjr.20190244","volume":"92","author":"R Guo","year":"2019","unstructured":"Guo, R. et al. The evolution of nasopharyngeal carcinoma staging. BJR 92, 20190244 (2019).","journal-title":"BJR"},{"key":"35795_CR9","unstructured":"Ferlay, J. et al. Global Cancer Observatory: Cancer Today (2018). (2020)."},{"key":"35795_CR10","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.radonc.2012.08.001","volume":"104","author":"AWM Lee","year":"2012","unstructured":"Lee, A. W. M. et al. The battle against nasopharyngeal cancer. Radiother. Oncol. 104, 272\u2013278 (2012).","journal-title":"Radiother. Oncol."},{"key":"35795_CR11","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1001\/archoto.2010.214","volume":"136","author":"MD Kernohan","year":"2010","unstructured":"Kernohan, M. D., Clark, J. R., Gao, K., Ebrahimi, A. & Milross, C. G. Predicting the prognosis of oral squamous cell carcinoma after first recurrence. Arch. Otolaryngol. Head Neck Surg. 136, 1235 (2010).","journal-title":"Arch. Otolaryngol. Head Neck Surg."},{"key":"35795_CR12","doi-asserted-by":"crossref","unstructured":"Zhu, Y., Song, X., Li, R., Quan, H. & Yan, L. Assessment of nasopharyngeal cancer in young patients aged \u2264 30 years. Front. Oncol. 9, (2019).","DOI":"10.3389\/fonc.2019.01179"},{"key":"35795_CR13","doi-asserted-by":"crossref","unstructured":"Lee, A. W. M. et al. The strength\/weakness of the AJCC\/UICC staging system (7th edition) for nasopharyngeal cancer and suggestions for future improvement. Oral Oncol. 48, 1007\u20131013 (2012).","DOI":"10.1016\/j.oraloncology.2012.03.022"},{"key":"35795_CR14","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1056\/NEJMoa032260","volume":"350","author":"J-C Lin","year":"2004","unstructured":"Lin, J.-C. et al. Quantification of plasma Epstein\u2013Barr virus DNA in patients with advanced nasopharyngeal carcinoma. N. Engl. J. Med. 350, 2461\u20132470 (2004).","journal-title":"N. Engl. J. Med."},{"key":"35795_CR15","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1002\/cncr.27853","volume":"119","author":"W-Y Wang","year":"2013","unstructured":"Wang, W.-Y. et al. Long-term survival analysis of nasopharyngeal carcinoma by plasma Epstein\u2013Barr virus DNA levels. Cancer 119, 963\u2013970 (2013).","journal-title":"Cancer"},{"key":"35795_CR16","doi-asserted-by":"publisher","first-page":"2208","DOI":"10.1158\/1078-0432.CCR-12-3702","volume":"19","author":"Q-T Le","year":"2013","unstructured":"Le, Q.-T. et al. An international collaboration to harmonize the quantitative plasma Epstein\u2013Barr virus DNA assay for future biomarker-guided trials in nasopharyngeal carcinoma. Clin. Cancer Res. 19, 2208\u20132215 (2013).","journal-title":"Clin. Cancer Res."},{"key":"35795_CR17","doi-asserted-by":"crossref","unstructured":"Pan, X.-X. et al. A simplified T classification based on the 8th edition of the UICC\/AJCC staging system for nasopharyngeal carcinoma. CMAR 11, 3163\u20133169 (2019).","DOI":"10.2147\/CMAR.S185860"},{"key":"35795_CR18","doi-asserted-by":"publisher","first-page":"153303382090982","DOI":"10.1177\/1533033820909829","volume":"19","author":"M Akcay","year":"2020","unstructured":"Akcay, M., Etiz, D., Celik, O. & Ozen, A. Evaluation of prognosis in nasopharyngeal cancer using machine learning. Technol. Cancer Res. Treat. 19, 153303382090982 (2020).","journal-title":"Technol. Cancer Res. Treat."},{"key":"35795_CR19","doi-asserted-by":"publisher","unstructured":"Alabi, R. O., Elmusrati, M., Leivo, I., Almangush, A. & M\u00e4kitie, A. A. Advanced-stage tongue squamous cell carcinoma: A machine learning model for risk stratification and treatment planning. Acta Oto-Laryngol. (2023) https:\/\/doi.org\/10.1080\/00016489.2023.2172208.","DOI":"10.1080\/00016489.2023.2172208"},{"key":"35795_CR20","doi-asserted-by":"publisher","first-page":"787","DOI":"10.3390\/jpm11080787","volume":"11","author":"RW Oei","year":"2021","unstructured":"Oei, R. W. et al. Progression-free survival prediction in patients with nasopharyngeal carcinoma after intensity-modulated radiotherapy: Machine learning vs traditional statistics. J. Personal. Med. 11, 787 (2021).","journal-title":"J. Personal. Med."},{"key":"35795_CR21","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1053\/j.ajkd.2019.02.016","volume":"74","author":"T Chen","year":"2019","unstructured":"Chen, T. et al. Prediction and risk stratification of kidney outcomes in IgA nephropathy. Am. J. Kidney Dis. 74, 300\u2013309 (2019).","journal-title":"Am. J. Kidney Dis."},{"key":"35795_CR22","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1002\/cam4.1021","volume":"6","author":"Y Li","year":"2017","unstructured":"Li, Y. et al. Nomograms to estimate long-term overall survival and tongue cancer-specific survival of patients with tongue squamous cell carcinoma. Cancer Med. 6, 1002\u20131013 (2017).","journal-title":"Cancer Med."},{"key":"35795_CR23","unstructured":"SEER, Program. Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) Research Data 1973\u20132009, National Cancer Institute, DCCPS, Surveillance Research Program, Surveillance Systems Branch, released April 2012, based on the November 2011 submission (2012)."},{"key":"35795_CR24","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1093\/ckj\/sfaa188","volume":"14","author":"CL Ramspek","year":"2021","unstructured":"Ramspek, C. L., Jager, K. J., Dekker, F. W., Zoccali, C. & van Diepen, M. External validation of prognostic models: What, why, how, when and where?. Clin. Kidney J. 14, 49\u201358 (2021).","journal-title":"Clin. Kidney J."},{"key":"35795_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijmedinf.2023.105064","volume":"175","author":"R Omobolaji Alabi","year":"2023","unstructured":"Omobolaji Alabi, R. et al. Application of artificial intelligence for overall survival risk stratification in oropharyngeal carcinoma: A validation of ProgTOOL. Int. J. Med. Inform. 175, 105064 (2023).","journal-title":"Int. J. Med. Inform."},{"key":"35795_CR26","doi-asserted-by":"crossref","unstructured":"Ribeiro, M. T., Singh, S. & Guestrin, C. \u2018Why Should i trust you?\u2019: Explaining the predictions of any classifier. arXiv:1602.04938 [cs, stat] (2016).","DOI":"10.1145\/2939672.2939778"},{"key":"35795_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/frai.2021.752558","volume":"4","author":"A Gramegna","year":"2021","unstructured":"Gramegna, A. & Giudici, P. SHAP and LIME: An Evaluation of discriminative power in credit risk. Front. Artif. Intell. 4, 752558 (2021).","journal-title":"Front. Artif. Intell."},{"key":"35795_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijmedinf.2022.104896","volume":"168","author":"R Alabi","year":"2022","unstructured":"Alabi, R., Almangush, A., Elmusrati, M., Leivo, I. & M\u00e4kitie, A. A. An interpretable machine learning prognostic system for risk stratification in oropharyngeal cancer. Int. J. Med. Inform. 168, 104896 (2022).","journal-title":"Int. J. Med. Inform."},{"key":"35795_CR29","unstructured":"Lundberg, S. M. & Lee, S.-I. A unified approach to interpreting model predictions. In 31st Conference on Neural Information Processing Systems (NIPS 2017), Long Beach, CA, USA. (2017)."},{"key":"35795_CR30","doi-asserted-by":"publisher","unstructured":"Joseph, A. Parametric inference with universal function approximators. (2019) https:\/\/doi.org\/10.48550\/ARXIV.1903.04209.","DOI":"10.48550\/ARXIV.1903.04209"},{"key":"35795_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijmedinf.2019.104068","author":"RO Alabi","year":"2019","unstructured":"Alabi, R. O. et al. Comparison of supervised machine learning classification techniques in prediction of locoregional recurrences in early oral tongue cancer. Int. J. Med. Inform. https:\/\/doi.org\/10.1016\/j.ijmedinf.2019.104068 (2019).","journal-title":"Int. J. Med. Inform."},{"key":"35795_CR32","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s00428-019-02642-5","volume":"475","author":"RO Alabi","year":"2019","unstructured":"Alabi, R. O. et al. Machine learning application for prediction of locoregional recurrences in early oral tongue cancer: A Web-based prognostic tool. Virchows Arch. 475, 489\u2013497 (2019).","journal-title":"Virchows Arch."},{"key":"35795_CR33","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.oraloncology.2019.03.011","volume":"92","author":"AM Bur","year":"2019","unstructured":"Bur, A. M. et al. Machine learning to predict occult nodal metastasis in early oral squamous cell carcinoma. Oral Oncol. 92, 20\u201325 (2019).","journal-title":"Oral Oncol."},{"key":"35795_CR34","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1001\/jamaoto.2019.0981","volume":"145","author":"OA Karadaghy","year":"2019","unstructured":"Karadaghy, O. A., Shew, M., New, J. & Bur, A. M. Development and assessment of a machine learning model to help predict survival among patients with oral squamous cell carcinoma. JAMA Otolaryngol. Head Neck Surg. 145, 1115 (2019).","journal-title":"JAMA Otolaryngol. Head Neck Surg."},{"key":"35795_CR35","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1001\/jamaoto.2017.0550","volume":"143","author":"OA Karadaghy","year":"2017","unstructured":"Karadaghy, O. A., Kallogjeri, D. & Piccirillo, J. F. Development of a new clinical severity staging system for patients with nonmetastatic papillary thyroid carcinoma. JAMA Otolaryngol. Head Neck Surg. 143, 1173 (2017).","journal-title":"JAMA Otolaryngol. Head Neck Surg."},{"key":"35795_CR36","doi-asserted-by":"publisher","unstructured":"Chen, T. & Guestrin, C. XGBoost: A scalable tree boosting system. In Proceedings of the 22nd ACM SIGKDD International Conference on Knowledge Discovery and Data Mining 785\u2013794 (ACM, 2016). https:\/\/doi.org\/10.1145\/2939672.2939785.","DOI":"10.1145\/2939672.2939785"},{"key":"35795_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2021.105335","volume":"118","author":"X Chen","year":"2021","unstructured":"Chen, X. et al. An interpretable machine learning prognostic system for locoregionally advanced nasopharyngeal carcinoma based on tumor burden features. Oral Oncol. 118, 105335 (2021).","journal-title":"Oral Oncol."},{"key":"35795_CR38","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1097\/COC.0000000000000091","volume":"39","author":"SN Hamilton","year":"2016","unstructured":"Hamilton, S. N. et al. Asian versus Non-Asian outcomes in nasopharyngeal carcinoma: A North American population-based analysis. Am. J. Clin. Oncol. 39, 575\u2013580 (2016).","journal-title":"Am. J. Clin. Oncol."},{"key":"35795_CR39","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s13293-021-00361-8","volume":"12","author":"W-Z Li","year":"2021","unstructured":"Li, W.-Z. et al. Age-dependent changes of gender disparities in nasopharyngeal carcinoma survival. Biol. Sex Differ. 12, 18 (2021).","journal-title":"Biol. Sex Differ."},{"key":"35795_CR40","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1007\/s00432-017-2401-y","volume":"143","author":"W-Z Qiu","year":"2017","unstructured":"Qiu, W.-Z. et al. A retrospective study comparing the outcomes and toxicities of intensity-modulated radiotherapy versus two-dimensional conventional radiotherapy for the treatment of children and adolescent nasopharyngeal carcinoma. J. Cancer Res. Clin. Oncol. 143, 1563\u20131572 (2017).","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"35795_CR41","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1186\/s12885-017-3552-6","volume":"17","author":"Y Li","year":"2017","unstructured":"Li, Y. et al. Concurrent chemoradiotherapy with or without cetuximab for stage II to IVb nasopharyngeal carcinoma: A case\u2013control study. BMC Cancer 17, 567 (2017).","journal-title":"BMC Cancer"},{"key":"35795_CR42","first-page":"381","volume":"33","author":"K Wei","year":"2014","unstructured":"Wei, K. et al. Nasopharyngeal carcinoma incidence and mortality in China in 2010. Chin. J. Cancer. 33, 381\u2013387 (2014).","journal-title":"Chin. J. Cancer."},{"key":"35795_CR43","doi-asserted-by":"publisher","first-page":"114","DOI":"10.5732\/cjc.010.10377","volume":"30","author":"S-M Cao","year":"2011","unstructured":"Cao, S.-M., Simons, M. J. & Qian, C.-N. The prevalence and prevention of nasopharyngeal carcinoma in China. Chin. J. Cancer 30, 114\u2013119 (2011).","journal-title":"Chin. J. Cancer"},{"key":"35795_CR44","doi-asserted-by":"crossref","unstructured":"Yeung, D. C. M., Yeung, Z., Wong, E. W. Y., Vlantis, A. C. & Chan, J. Y. K. Neck lymph node status on survival of regionally recurrent or persistent nasopharyngeal carcinoma. Sci. Rep. 10, (2020).","DOI":"10.1038\/s41598-020-62625-4"},{"key":"35795_CR45","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/s10654-007-9148-8","volume":"22","author":"J Luo","year":"2007","unstructured":"Luo, J. et al. Secular trends of nasopharyngeal carcinoma incidence in Singapore, Hong Kong and Los Angeles Chinese populations, 1973\u20131997. Eur. J. Epidemiol. 22, 513\u2013521 (2007).","journal-title":"Eur. J. Epidemiol."},{"key":"35795_CR46","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1093\/jjco\/hyi245","volume":"36","author":"S-A Yeh","year":"2006","unstructured":"Yeh, S.-A., Tang, Y., Lui, C.-C. & Huang, E.-Y. Treatment outcomes of patients with AJCC Stage IVC nasopharyngeal carcinoma: Benefits of primary radiotherapy. Jpn. J. Clin. Oncol. 36, 132\u2013136 (2006).","journal-title":"Jpn. J. Clin. Oncol."},{"key":"35795_CR47","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1097\/COC.0b013e31821a9452","volume":"35","author":"S Lin","year":"2012","unstructured":"Lin, S. et al. Combined high-dose radiation therapy and systemic chemotherapy improves survival in patients with newly diagnosed metastatic nasopharyngeal cancer. Am. J. Clin. Oncol. 35, 474\u2013479 (2012).","journal-title":"Am. J. Clin. Oncol."},{"key":"35795_CR48","doi-asserted-by":"publisher","first-page":"604","DOI":"10.5732\/cjc.013.10148","volume":"32","author":"M-Y Chen","year":"2013","unstructured":"Chen, M.-Y. et al. Locoregional radiotherapy in patients with distant metastases of nasopharyngeal carcinoma at diagnosis. Chin. J. Cancer 32, 604\u2013613 (2013).","journal-title":"Chin. J. Cancer"},{"key":"35795_CR49","doi-asserted-by":"publisher","first-page":"2845","DOI":"10.1002\/1097-0142(20011201)92:11<2845::AID-CNCR10133>3.0.CO;2-7","volume":"92","author":"DTT Chua","year":"2001","unstructured":"Chua, D. T. T., Sham, J. S. T., Wei, W. I., Ho, W.-K. & Au, G. K. H. The predictive value of the 1997 American Joint Committee on Cancer stage classification in determining failure patterns in nasopharyngeal carcinoma. Cancer 92, 2845\u20132855 (2001).","journal-title":"Cancer"},{"key":"35795_CR50","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1016\/j.ijrobp.2008.12.015","volume":"75","author":"S Lin","year":"2009","unstructured":"Lin, S. et al. Nasopharyngeal carcinoma treated with reduced-volume intensity-modulated radiation therapy: Report on the 3-year outcome of a prospective series. Int. J. Radiat. Oncol. Biol. Phys. 75, 1071\u20131078 (2009).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"35795_CR51","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s12967-017-1204-x","volume":"15","author":"J Sun","year":"2017","unstructured":"Sun, J., Huang, Z., Hu, Z. & Sun, R. Benefits of local tumor excision and pharyngectomy on the survival of nasopharyngeal carcinoma patients: A retrospective observational study based on SEER database. J. Transl. Med. 15, 116 (2017).","journal-title":"J. Transl. Med."},{"key":"35795_CR52","doi-asserted-by":"publisher","first-page":"3349","DOI":"10.1007\/s13277-015-4148-x","volume":"37","author":"Q Zhu","year":"2016","unstructured":"Zhu, Q. et al. Overexpression of acylglycerol kinase is associated with poorer prognosis and lymph node metastasis in nasopharyngeal carcinoma. Tumor Biol. 37, 3349\u20133357 (2016).","journal-title":"Tumor Biol."},{"key":"35795_CR53","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1016\/j.ejca.2010.04.004","volume":"46","author":"ARA Razak","year":"2010","unstructured":"Razak, A. R. A. et al. Nasopharyngeal carcinoma: The next challenges. Eur. J. Cancer 46, 1967\u20131978 (2010).","journal-title":"Eur. J. Cancer"},{"key":"35795_CR54","doi-asserted-by":"crossref","unstructured":"Tian, Y. et al. Prognostic model and optimal treatment for patients with stage IVc nasopharyngeal carcinoma at diagnosis. Sci. Rep. 9, (2019).","DOI":"10.1038\/s41598-019-55586-w"},{"key":"35795_CR55","doi-asserted-by":"publisher","first-page":"2423","DOI":"10.1002\/(SICI)1097-0142(19960615)77:12<2423::AID-CNCR2>3.0.CO;2-N","volume":"77","author":"PML Teo","year":"1996","unstructured":"Teo, P. M. L., Kwan, W. H., Lee, W. Y., Leung, S. F. & Johnson, P. J. Prognosticators determining survival subsequent to distant metastasis from nasopharyngeal carcinoma. Cancer 77, 2423\u20132431 (1996).","journal-title":"Cancer"},{"key":"35795_CR56","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1016\/S0959-8049(03)00310-1","volume":"39","author":"YK Ong","year":"2003","unstructured":"Ong, Y. K. et al. Design of a prognostic index score for metastatic nasopharyngeal carcinoma. Eur. J. Cancer 39, 1535\u20131541 (2003).","journal-title":"Eur. J. Cancer"},{"key":"35795_CR57","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1200\/JCO.2000.18.6.1324","volume":"18","author":"A Fandi","year":"2000","unstructured":"Fandi, A. et al. Long-term disease-free survivors in metastatic undifferentiated carcinoma of nasopharyngeal type. J. Clin. Oncol. 18, 1324\u20131330 (2000).","journal-title":"J. Clin. Oncol."},{"key":"35795_CR58","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.canrad.2007.06.006","volume":"11","author":"A Khanfir","year":"2007","unstructured":"Khanfir, A., Frikha, M., Ghorbel, A., Drira, M. M. & Daoud, J. Prognostic factors in metastatic nasopharyngeal carcinoma. Cancer\/Radioth\u00e9rapie 11, 461\u2013464 (2007).","journal-title":"Cancer\/Radioth\u00e9rapie"},{"key":"35795_CR59","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.ejca.2011.09.004","volume":"48","author":"Y Jin","year":"2012","unstructured":"Jin, Y. et al. To build a prognostic score model containing indispensible tumour markers for metastatic nasopharyngeal carcinoma in an epidemic area. Eur. J. Cancer 48, 882\u2013888 (2012).","journal-title":"Eur. J. Cancer"},{"key":"35795_CR60","doi-asserted-by":"publisher","first-page":"334","DOI":"10.3892\/etm.2012.584","volume":"4","author":"C-C Pan","year":"2012","unstructured":"Pan, C.-C. et al. Challenges in the modification of the M1 stage of the TNM staging system for nasopharyngeal carcinoma: A study of 1027 cases and review of the literature. Exp. Ther. Med. 4, 334\u2013338 (2012).","journal-title":"Exp. Ther. Med."},{"key":"35795_CR61","unstructured":"AJCC Cancer Staging Handbook: From the AJCC Cancer Staging Manual. (Springer, 2010)."},{"key":"35795_CR62","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1002\/hed.21608","volume":"34","author":"J Setton","year":"2012","unstructured":"Setton, J., Wolden, S., Caria, N. & Lee, N. Definitive treatment of metastatic nasopharyngeal carcinoma: Report of 5 cases with review of literature. Head Neck 34, 753\u2013757 (2012).","journal-title":"Head Neck"},{"key":"35795_CR63","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1007\/s12032-015-0663-2","volume":"32","author":"S Hu","year":"2015","unstructured":"Hu, S. et al. Systemic chemotherapy followed by locoregional definitive intensity-modulated radiation therapy yields prolonged survival in nasopharyngeal carcinoma patients with distant metastasis at initial diagnosis. Med. Oncol. 32, 224 (2015).","journal-title":"Med. Oncol."},{"key":"35795_CR64","doi-asserted-by":"crossref","unstructured":"Qiu, W.-Z. et al. Neoadjuvant chemotherapy plus intensity-modulated radiotherapy versus concurrent chemoradiotherapy plus adjuvant chemotherapy for the treatment of locoregionally advanced nasopharyngeal carcinoma: A retrospective controlled study. Chin. J. Cancer 35, (2016).","DOI":"10.1186\/s40880-015-0076-9"},{"key":"35795_CR65","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.ijrobp.2019.06.2549","volume":"105","author":"X-S Sun","year":"2019","unstructured":"Sun, X.-S. et al. The association between the development of radiation therapy, image technology, and chemotherapy, and the survival of patients with nasopharyngeal carcinoma: A cohort study from 1990 to 2012. Int. J. Radiat. Oncol. Biol. Phys. 105, 581\u2013590 (2019).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"35795_CR66","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.radonc.2012.08.013","volume":"104","author":"G Peng","year":"2012","unstructured":"Peng, G. et al. A prospective, randomized study comparing outcomes and toxicities of intensity-modulated radiotherapy vs. conventional two-dimensional radiotherapy for the treatment of nasopharyngeal carcinoma. Radiother. Oncol. 104, 286\u2013293 (2012).","journal-title":"Radiother. Oncol."},{"key":"35795_CR67","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1200\/JCO.2008.18.1545","volume":"27","author":"EP Hui","year":"2009","unstructured":"Hui, E. P. et al. Randomized phase II trial of concurrent cisplatin-radiotherapy with or without neoadjuvant docetaxel and cisplatin in advanced nasopharyngeal carcinoma. JCO 27, 242\u2013249 (2009).","journal-title":"JCO"},{"key":"35795_CR68","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0219611","volume":"14","author":"T Du","year":"2019","unstructured":"Du, T., Xiao, J., Qiu, Z. & Wu, K. The effectiveness of intensity-modulated radiation therapy versus 2D-RT for the treatment of nasopharyngeal carcinoma: A systematic review and meta-analysis. PLoS ONE 14, e0219611 (2019).","journal-title":"PLoS ONE"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-35795-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-35795-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-35795-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,2]],"date-time":"2023-06-02T08:10:20Z","timestamp":1685693420000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-35795-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,2]]},"references-count":68,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["35795"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-35795-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,2]]},"assertion":[{"value":"14 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8984"}}